Search Results

There are 11464 results for: content related to: Phase 2 study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: ECOG 3204

  1. Anti-angiogenic therapies for metastatic colorectal cancer

    Intervention Review

    The Cochrane Library

    Anna Dorothea ADW Wagner, Dirk Arnold, Axel AG Grothey, Johannes Haerting and Susanne Unverzagt

    Published Online : 8 JUL 2009, DOI: 10.1002/14651858.CD005392.pub3

  2. Cancer of the Colon and Rectum

    Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach

    Rachel S. Midgley, Omar Khan, Andrew Weaver, Daniel Royston, Bryan Warren, Margaret Betts, Baljit Singh, Chris Cunningham, Ami Sabharwal, David Kerr, Robert Glynne-Jones, Zahir Soonwalla, Fergus Gleeson, Carlos Escriu, Mark Middleton, Ann MacArthur, Julia Liddi, Pages: 325–373, 2009

    Published Online : 14 JAN 2009, DOI: 10.1002/9781444300147.ch14

  3. You have full text access to this OnlineOpen article
    A systematic review of treatment guidelines for metastatic colorectal cancer

    Colorectal Disease

    Volume 14, Issue 2, February 2012, Pages: e31–e47, M. S. Edwards, S. D. Chadda, Z. Zhao, B. L. Barber and D. P. Sykes

    Article first published online : 10 JAN 2012, DOI: 10.1111/j.1463-1318.2011.02765.x

  4. You have free access to this content
    A phase 1 study of hepatic arterial infusion of oxaliplatin in combination with systemic 5-fluorouracil, leucovorin, and bevacizumab in patients with advanced solid tumors metastatic to the liver

    Cancer

    Volume 116, Issue 17, 1 September 2010, Pages: 4086–4094, Apostolia M. Tsimberidou, Siqing Fu, Chaan Ng, Jo Ann Lim, Sijin Wen, David Hong, Jennifer Wheler, Agop Y. Bedikian, Cathy Eng, Michael Wallace, Luis H. Camacho and Razelle Kurzrock

    Article first published online : 19 AUG 2010, DOI: 10.1002/cncr.25277

  5. Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis

    Cancer

    Volume 121, Issue 20, October 15, 2015, Pages: 3649–3658, Robert C. G. Martin II, Charles R. Scoggins, Marshall Schreeder, William S. Rilling, Christopher J. Laing, Clifton M. Tatum, Lawrence R. Kelly, Ricardo D. Garcia-Monaco, Vivek R. Sharma, Todd S. Crocenzi and Steven M. Strasberg

    Article first published online : 6 JUL 2015, DOI: 10.1002/cncr.29534

  6. Future Directions in the Oncological Treatment of Colorectal Cancer

    Challenges in Colorectal Cancer

    Anthony El-Khoueiry, Heinz-Josef Lenz, Pages: 251–270, 2008

    Published Online : 14 JAN 2008, DOI: 10.1002/9780470753231.ch16

  7. You have free access to this content
    Axitinib and/or bevacizumab with modified FOLFOX-6 as first-line therapy for metastatic colorectal cancer: A randomized phase 2 study

    Cancer

    Volume 119, Issue 14, 15 July 2013, Pages: 2555–2563, Jeffrey R. Infante, Tony R. Reid, Allen L. Cohn, William J. Edenfield, Terrence P. Cescon, John T. Hamm, Imtiaz A. Malik, Thomas A. Rado, Philip J. McGee, Donald A. Richards, Jamal Tarazi, Brad Rosbrook, Sinil Kim and Thomas H. Cartwright

    Article first published online : 19 APR 2013, DOI: 10.1002/cncr.28112

  8. Effect of bevacizumab added preoperatively to oxaliplatin on liver injury and complications after resection of colorectal liver metastases

    Journal of Surgical Oncology

    Volume 106, Issue 7, 1 December 2012, Pages: 892–897, Anne E.M. van der Pool, Hendrick A. Marsman, Joanne Verheij, Fibo J. Ten Kate, Alexander M.M. Eggermont, Jan N.M. IJzermans and Cornelis Verhoef

    Article first published online : 2 MAY 2012, DOI: 10.1002/jso.23142

  9. You have free access to this content
    Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement

    HPB

    Volume 15, Issue 2, February 2013, Pages: 106–115, Roderich E. Schwarz, Jordan D. Berlin, Heinz J. Lenz, Bernard Nordlinger, Laura Rubbia-Brandt and Michael A. Choti

    Article first published online : 24 SEP 2012, DOI: 10.1111/j.1477-2574.2012.00558.x

  10. Colorectal Cancer

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 15 SEP 2006, DOI: 10.1002/9780470041000.cedt009

  11. Anti-EGFR Monoclonal Antibodies for Treatment of Colorectal Cancers: Development of Cetuximab and Panitumumab

    The Journal of Clinical Pharmacology

    Volume 52, Issue 2, February 2012, Pages: 128–155, Dr Benoit You and Dr Eric X. Chen

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270010395940

  12. The application of pharmacoeconomic modelling to estimate a value-based price for new cancer drugs

    Journal of Evaluation in Clinical Practice

    Volume 18, Issue 2, April 2012, Pages: 343–351, George Dranitsaris, Ilse Truter, Martie S. Lubbe, Wayne Cottrell, Biljana Spirovski and Jonathan Edwards

    Article first published online : 18 NOV 2010, DOI: 10.1111/j.1365-2753.2010.01565.x

  13. You have free access to this content
    RESEARCH POSTER ABSTRACTS

    Value in Health

    Volume 13, Issue 7, November 2010, Pages: A250–A480,

    Article first published online : 11 OCT 2010, DOI: 10.1111/j.1524-4733.2010.00791_2.x

  14. You have free access to this content
    RESEARCH PODIUM ABSTRACTS

    Value in Health

    Volume 13, Issue 7, November 2010, Pages: A239–A250,

    Article first published online : 11 OCT 2010, DOI: 10.1111/j.1524-4733.2010.00791_1.x

  15. Biologic modulation of chemotherapy in patients with hepatic colorectal metastases: The role of anti-VEGF and anti-EGFR antibodies

    Journal of Surgical Oncology

    Volume 102, Issue 8, 15 December 2010, Pages: 937–945, Ravit Geva, Hans Prenen, Baki Topal, Raymond Aerts, Jaarke Vannoote and Eric Van Cutsem

    Article first published online : 16 DEC 2010, DOI: 10.1002/jso.21760

  16. You have free access to this content
    A double-blind, randomized, placebo-controlled, phase 2 study of maintenance enzastaurin with 5-fluorouracil/leucovorin plus bevacizumab after first-line therapy for metastatic colorectal cancer

    Cancer

    Volume 118, Issue 17, 1 September 2012, Pages: 4132–4138, Robert A. Wolff, Martin Fuchs, Maria Di Bartolomeo, Anwar M. Hossain, Clemens Stoffregen, Steven Nicol and Volker Heinemann

    Article first published online : 27 DEC 2011, DOI: 10.1002/cncr.26692

  17. Retrospective analysis on the efficacy of bevacizumab with FOLFOX as a first-line treatment in Japanese patients with metastatic colorectal cancer

    Asia-Pacific Journal of Clinical Oncology

    Volume 10, Issue 4, December 2014, Pages: 322–329, Mitsukuni Suenaga, Nobuyuki Mizunuma, Satoshi Matsusaka, Eiji Shinozaki, Masashi Ueno and Toshiharu Yamaguchi

    Article first published online : 5 AUG 2013, DOI: 10.1111/ajco.12094

  18. Optimum chemotherapy regimens for neoadjuvant therapy of hepatic colorectal metastases

    Journal of Surgical Oncology

    Volume 102, Issue 8, 15 December 2010, Pages: 946–954, Janine M. Davies and Richard M. Goldberg

    Article first published online : 16 DEC 2010, DOI: 10.1002/jso.21653

  19. You have full text access to this OnlineOpen article
    Phase I/II trial of capecitabine, oxaliplatin, and irinotecan in combination with bevacizumab in first line treatment of metastatic colorectal cancer

    Cancer Medicine

    Volume 4, Issue 10, October 2015, Pages: 1505–1513, Shouki Bazarbashi, Ali Aljubran, Ahmad Alzahrani, Ahmed Mohieldin, Hussein Soudy and Mohammed Shoukri

    Article first published online : 24 JUL 2015, DOI: 10.1002/cam4.497

  20. You have free access to this content
    Systemic therapy for metastatic colorectal cancer

    Cancer

    Volume 112, Issue 9, 1 May 2008, Pages: 1879–1891, Dan S. Zuckerman and Jeffrey W. Clark

    Article first published online : 13 MAR 2008, DOI: 10.1002/cncr.23409